Piperacillin Impurity 6
 
		Product Description
CAT No.
				
									ALN-P048022								
				CAS No.
				
									NA								
				Mol. F.
				
									C23H29N5O8S								
				Mol. Wt.
				
									535.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (2R,4S)-2-((S)-carboxy((R)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetamido)methyl)-5,5-dimethylthiazolidine-4-carboxylic acid								
				
									Smiles : [H][C@@]1(SC(C)([C@@H](N1)C(O)=O)C)[C@@H](NC([C@H](NC(N(CCN2CC)C(C2=O)=O)=O)C3=CC=CC=C3)=O)C(O)=O								
				
									Inchi : InChI=1S/C41H48N8O10S2/c1-7-46-19-20-47(35(56)34(46)55)39(58)45-24(22-17-13-10-14-18-22)30(51)44-25-32(53)48-27(40(3,4)60-36(25)48)31(52)42-23(21-15-11-9-12-16-21)29(50)43-26-33(54)49-28(38(57)59-8-2)41(5,6)61-37(26)49/h9-18,23-28,36-37H,7-8,19-20H2,1-6H3,(H,42,52)(H,43,50)(H,44,51)(H,45,58)/t23-,24-,25-,26-,27+,28+,36?,37?/m1/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Quantification of cefepime, meropenem, piperacillin, and tazobactam in human plasma using a sensitive and robust liquid chromatography-tandem mass spectrometry method, part 2: stability evaluation
									By D’cunha, Ronilda; Bach, Thanh; Young, Beth Ann; Li, Peizhi; Nalbant, Demet; Zhang, Jun; Winokur, Patricia; An, GuohuanFrom Antimicrobial Agents and Chemotherapy (2018), 62(9), e00861-18/1-e00861-18/9								
				Stability indicating RP-HPLC method for the determination of Piperacillin and Tazobactam and their related substances in bulk and pharmaceutical formulation
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            